What is Evoke Pharma?
Evoke Pharma operates as a dedicated specialty pharmaceutical entity, primarily concentrating on the development and commercialization of innovative treatments for gastrointestinal (GI) disorders and diseases. The company's flagship asset, GIMOTI, represents a significant advancement in therapeutic delivery, utilizing a proprietary nasal spray formulation of metoclopramide. This solution is specifically engineered to address the debilitating symptoms associated with acute and recurrent diabetic gastroparesis in adult populations. By targeting niche therapeutic areas with high unmet medical needs, Evoke Pharma distinguishes itself from broader pharmaceutical competitors through its commitment to precision medicine and patient-centric drug delivery systems.
How much funding has Evoke Pharma raised?
Evoke Pharma has raised a total of $28.7M across 2 funding rounds:
Stock Offering
$25.2M
Stock Offering
$3.5M
Stock Issuance/Offering (2013): $25.2M, investors not publicly disclosed
Stock Issuance/Offering (2024): $3.5M, investors not publicly disclosed
Key Investors in Evoke Pharma
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Evoke Pharma?
With the recent influx of capital, Evoke Pharma is well-positioned to accelerate its commercialization efforts and expand the market reach of its existing portfolio. The strategic allocation of these funds will likely prioritize the scaling of distribution channels for GIMOTI and the potential exploration of secondary indications for its core technology. As the company transitions into a more mature phase of its lifecycle, the focus will shift toward sustaining long-term revenue growth and optimizing its clinical development pipeline. Investors will be monitoring the firm's ability to capture market share in the GI space while maintaining the rigorous regulatory standards required for specialty pharmaceutical products.
See full Evoke Pharma company page
